CareRx Corporation (FRA:29C1)
Germany · Delayed Price · Currency is EUR 2.320
-0.060 (-2.52%)
Last updated: Jan 19, 2026, 8:01 AM CET
CareRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 366.34 | 366.71 | 370.75 | 381.73 | 262.63 | 162.2 | |
Revenue Growth (YoY) | 0.19% | -1.09% | -2.88% | 45.35% | 61.92% | 30.15% |
Cost of Revenue | 257.14 | 258.65 | 266.05 | 271.79 | 187.35 | 115.14 |
Gross Profit | 109.2 | 108.06 | 104.7 | 109.93 | 75.28 | 47.05 |
Selling, General & Admin | 100.38 | 101.28 | 97.87 | 102.55 | 70.52 | 47.98 |
Operating Expenses | 100.38 | 101.28 | 97.87 | 102.55 | 70.52 | 47.98 |
Operating Income | 8.83 | 6.78 | 6.83 | 7.38 | 4.76 | -0.93 |
Interest Expense | -7.1 | -8.9 | -13.86 | -14.89 | -14.65 | -9.69 |
Interest & Investment Income | 0.13 | 0.06 | 1.26 | 0.28 | 0.06 | 0.06 |
Other Non Operating Income (Expenses) | -0.29 | -0.29 | -0.13 | 5.24 | -2.24 | 2.64 |
EBT Excluding Unusual Items | 1.57 | -2.34 | -5.91 | -1.98 | -12.08 | -7.92 |
Merger & Restructuring Charges | -1.37 | -1.49 | -1.45 | -5 | -8.06 | -11.4 |
Impairment of Goodwill | - | -0.76 | -0.71 | -22.52 | - | - |
Gain (Loss) on Sale of Investments | - | - | - | -2.71 | - | 0.76 |
Asset Writedown | - | - | - | -1.81 | - | - |
Other Unusual Items | -0.08 | 0.13 | -1.53 | -1.87 | -3.6 | 0.25 |
Pretax Income | 0.13 | -4.47 | -9.6 | -35.9 | -23.74 | -18.3 |
Income Tax Expense | 0.03 | 0.03 | -4.19 | -1.54 | -1.01 | -0.12 |
Earnings From Continuing Operations | 0.09 | -4.5 | -5.41 | -34.35 | -22.73 | -18.18 |
Earnings From Discontinued Operations | - | - | - | - | - | -0.08 |
Net Income to Company | 0.09 | -4.5 | -5.41 | -34.35 | -22.73 | -18.26 |
Net Income | 0.09 | -4.5 | -5.41 | -34.35 | -22.73 | -18.26 |
Net Income to Common | 0.09 | -4.5 | -5.41 | -34.35 | -22.73 | -18.26 |
Shares Outstanding (Basic) | 62 | 60 | 57 | 48 | 35 | 20 |
Shares Outstanding (Diluted) | 64 | 60 | 57 | 48 | 35 | 20 |
Shares Change (YoY) | 6.72% | 5.06% | 20.49% | 36.54% | 72.00% | 84.63% |
EPS (Basic) | 0.00 | -0.07 | -0.09 | -0.72 | -0.65 | -0.90 |
EPS (Diluted) | 0.00 | -0.07 | -0.09 | -0.72 | -0.65 | -0.90 |
Free Cash Flow | 22.68 | 32.4 | 22.65 | 12.29 | 1.92 | -1.33 |
Free Cash Flow Per Share | 0.36 | 0.54 | 0.40 | 0.26 | 0.06 | -0.07 |
Gross Margin | 29.81% | 29.47% | 28.24% | 28.80% | 28.66% | 29.01% |
Operating Margin | 2.41% | 1.85% | 1.84% | 1.93% | 1.81% | -0.57% |
Profit Margin | 0.03% | -1.23% | -1.46% | -9.00% | -8.65% | -11.26% |
Free Cash Flow Margin | 6.19% | 8.84% | 6.11% | 3.22% | 0.73% | -0.82% |
EBITDA | 20.48 | 22.06 | 22.89 | 21.74 | 16.96 | 8.35 |
EBITDA Margin | 5.59% | 6.02% | 6.17% | 5.69% | 6.46% | 5.15% |
D&A For EBITDA | 11.66 | 15.28 | 16.07 | 14.35 | 12.21 | 9.27 |
EBIT | 8.83 | 6.78 | 6.83 | 7.38 | 4.76 | -0.93 |
EBIT Margin | 2.41% | 1.85% | 1.84% | 1.93% | 1.81% | -0.57% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.